ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Grifols SA (PK)

Grifols SA (PK) (GIFOF)

8,85
0,00
(0,00%)
Fermé 07 Juin 10:00PM

Grifols SA (PK) (GIFOF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
8,85
( - )
Prix Achat
7,23
Prix Vente
8,86
Volume échangé
-
0,00 Fourchette du Jour 0,00
8,20 Plage de 52 semaines 8,85
Cap du marché
Clôture Veille
8,85
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 2 779 726
Actions en circulation
680 575 312
Rendement du Dividende (LTM)
(3,36%)
Ratio Cours sur Bénéfices
14,71
Bénéfice par action (BPA)
-
Chiffre d'affairess (LTM)
7,44B
Bénéfice net (LTM)
415M

À propos de Grifols SA (PK)

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company... Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Barcelona, Spain
Fondé
2026
Grifols SA (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker GIFOF. Le dernier cours de clôture d'Grifols (PK) était de US$8,85. Au cours de la dernière année, les actions de Grifols (PK) ont été négociées dans une fourchette de prix de US$ 8,20 à US$ 8,85.

Grifols (PK) compte actuellement 680 575 312 actions en circulation. La capitalisation boursière d'Grifols (PK) est de US$6,02 milliard. Grifols (PK) a un ratio cours/bénéfice (ratio PE) de 14.71.

GIFOF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120.657.926829268298.28.858.212308.21575053CS
260.0350.3970504821338.8158.858.26278.22838699CS
520.0350.3970504821338.8158.858.22908.23867523CS
156-0.3217-3.507528593399.171710.215.58626917.83197216CS
260-8.896-50.129606671917.74619.4465.58353319.17820801CS

GIFOF - Frequently Asked Questions (FAQ)

What is the current Grifols SA (PK) share price?
The current share price of Grifols SA (PK) is US$ 8,85
How many Grifols SA (PK) shares are in issue?
Grifols SA (PK) has 680 575 312 shares in issue
What is the market cap of Grifols SA (PK)?
The market capitalisation of Grifols SA (PK) is USD 6,02B
What is the 1 year trading range for Grifols SA (PK) share price?
Grifols SA (PK) has traded in the range of US$ 8,20 to US$ 8,85 during the past year
What is the PE ratio of Grifols SA (PK)?
The price to earnings ratio of Grifols SA (PK) is 14,71
What is the cash to sales ratio of Grifols SA (PK)?
The cash to sales ratio of Grifols SA (PK) is 0,73
What is the registered address of Grifols SA (PK)?
The registered address for Grifols SA (PK) is Parque Empresarial Can Sant Joan, Barcelona, Catalonia, 08174
What is the Grifols SA (PK) website address?
The website address for Grifols SA (PK) is www.grifols.com
Which industry sector does Grifols SA (PK) operate in?
Grifols SA (PK) operates in the Pharmaceuticals sector

GIFOF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock